Company profile

Radiopharm Theranostics Limited

Pipeline7 assets

18F-PivalateRAD 101 / FASN (Fatty acid synthase) / Small Molecule Radiopharmaceutical / Diagnostics
Brain metastases from solid tumors (Imaging)Phase 2bEnrollingUS
177Lu-RAD202RAD 202 / HER2 / Nanobody Radiotherapeutic / Oncology
HER2-positive advanced solid tumorsPhase 1ActiveUSGlobal
177Lu-RAD204RAD 204 / PD-L1 / Nanobody Radiotherapeutic / Oncology
PD-L1 positive advanced solid tumorsPhase 1ActiveUSGlobal
68Ga-TrivehexinRAD 301 / αvβ6-integrin / Peptide Radiopharmaceutical / Diagnostics
Loco-regional pancreatic cancer (Imaging)Phase 2ActiveGlobal
177Lu-D0301RAD 302 / αvβ6-integrin / Peptide Radiotherapeutic / Oncology
Solid tumors (PDAC, NSCLC, HNSCC)PreclinicalActiveGlobal
BetaBartRV-01 / B7-H3 / Radiotherapeutic / Oncology
B7H3-expressing solid tumorsPhase 1/2aActiveUS
161Tb-RAD 402RAD 402 / KLK3 (PSA) / Monoclonal Antibody Radiotherapeutic / Oncology
Advanced prostate cancerPhase 1ActiveAustralia